Skip to main content
OpenTrials

Clinical trial condition

Carcinoma

Explore clinical trials studying Carcinoma. Study availability and eligibility vary by location and protocol.

150 public trials 27 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma trial results

Active, Not Recruiting

Use of a Pre-Surgical Toolkit in Improving Surgical Care and Outcomes in Older Participants With Cancer

NCT03857620

Conditions
Carcinoma, Health Care Provider, Malignant Neoplasm, +4 more
Locations
  • Helen F Graham Cancer Center Newark, Delaware, United States
  • MedStar Washington Hospital Center Washington D.C., District of Columbia, United States
  • Augusta University Medical Center Augusta, Georgia, United States
  • Memorial Health University Medical Center Savannah, Georgia, United States
View all 44 locations
View Trial Details
Active, Not Recruiting

Osimertinib Plus Savolitinib in EGFRm+/MET+ NSCLC Following Prior Osimertinib

NCT03778229

Conditions
Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +10 more
Locations
  • Research Site La Jolla, California, United States
  • Research Site Los Angeles, California, United States
  • Research Site Sacramento, California, United States
  • Research Site Washington D.C., District of Columbia, United States
View all 90 locations
View Trial Details
Active, Not Recruiting

Savolitinib Plus Osimertinib Versus Platinum-based Doublet Chemotherapy in Participants With Non-Small Cell Lung Cancer Who Have Progressed on Osimertinib Treatment

NCT05261399

Conditions
Carcinoma, Neoplasm Metastasis, Neoplasms, +6 more
Locations
  • Research Site Orlando, Florida, United States
  • Research Site Honolulu, Hawaii, United States
  • Research Site New Brunswick, New Jersey, United States
  • Research Site New York, United States
View all 226 locations
View Trial Details
Active, Not Recruiting

A Study of Dostarlimab in Combination With Carboplatin-paclitaxel in Japanese Participants With Primary Advanced or Recurrent Endometrial Cancer

NCT06317311

Conditions
Carcinoma, Endometrial Neoplasms, Female Urogenital Diseases, +12 more
Locations
  • GSK Investigational Site Aichi, Japan
  • GSK Investigational Site Chiba, Japan
  • GSK Investigational Site Ehime, Japan
  • GSK Investigational Site Fukuoka, Japan
View all 20 locations
View Trial Details
Active, Not Recruiting

Anlotinib Combined With Carboplatin/Paclitaxel as First-line Treatment in Patients With Advanced Ovarian Cancer

NCT04807166

Conditions
Adnexal Diseases, Angiogenesis, Anlotinib, +22 more
Locations
  • Huai'an First People's Hospital Huai'an, China
  • Nanjing Drum Tower Hospital Nanjing, China
  • Zhongda Hospital Southeast University Nanjing, China
  • The First Affiliated Hospital of Soochow University Suzhou, China
View Trial Details

Related conditions